What is Xeris Biopharma Holdings, Inc.'s change in AP?

Xeris Biopharma Holdings, Inc. (XERS) reported change in AP of $4.25M in Q1 2026.

How has Xeris Biopharma Holdings, Inc.'s change in AP changed year-over-year?

Xeris Biopharma Holdings, Inc.'s change in AP increased by 4.6% year-over-year, from $4.06M to $4.25M.

What does change in AP mean?

Increase or decrease in amounts owed to suppliers — a key working capital component affecting operating cash flow.

Xeris Biopharma Holdings, Inc. XERS Change in AP

Change in AP at other companies

Eli LillyLLY

$2.55B+290%

Corcept TherapeuticsCORT

-$7.64M-161%

ANI PharmaceuticalsANIP

$5.36M-3.4%

Crinetics PharmaceuticalsCRNX

-$12.06M-790%

Catalyst PharmaceuticalCPRX

-$4.05M+24.9%

BridgeBio PharmaBBIO

-$7.17M-141%

Other financials

Income statement

See full

Revenue$83.1M+38.3%

Gross profit$72.6M+41.2%

Operating income$7.9M+356%

Net income$2.2M+124%

EPS (diluted)$0.01+117%

Balance sheet

See full

Cash & equivalents$111.8M+91.2%

Total debt$258.6M-3.8%

Total equity$13.0M+137%

Total assets$392.0M+24.3%

Cash flow

See full

Operating cash flow$9.9M+198%

CapEx$131.0K—

Free cash flow-$29.1M—

Valuation

See full

Market cap$1.28B+18.3%

Enterprise value$1.42B+8.7%

P/E106.4×—

P/S4.1×-0.8×

Profitability

See full

Gross margin85.9%+3.7pp

Operating margin11.4%+7.7pp

Net margin3.8%+2.1pp

Returns & leverage

See full

Return on equity-209.8%—

Debt / equity19.9×—

Current ratio2.1×+0.4×

Where this comes from

Reported directly by Xeris Biopharma Holdings, Inc. in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsPayable.

The official record: Xeris Biopharma Holdings, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Xeris Biopharma Holdings, Inc.'s change in ap.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Xeris Biopharma Holdings, Inc.'s change in AP?: Xeris Biopharma Holdings, Inc. (XERS) reported change in AP of $4.25M in Q1 2026.
How has Xeris Biopharma Holdings, Inc.'s change in AP changed year-over-year?: Xeris Biopharma Holdings, Inc.'s change in AP increased by 4.6% year-over-year, from $4.06M to $4.25M.
What does change in AP mean?: Increase or decrease in amounts owed to suppliers — a key working capital component affecting operating cash flow.